Beyond the Headline

Most people on Ozempic and Wegovy now take them to lose weight, and that shift is already changing grocery shelves, clothing racks, Medicare budgets and maybe even how people spend.

Show Notes

In this episode of Beyond the Headline: Most people on Ozempic and Wegovy now take them to lose weight, and that shift is already changing grocery shelves, clothing racks, Medicare budgets and maybe even how people spend. This podcast is AI-generated. Every episode is produced and voiced by AI and disclosed as such.

What is Beyond the Headline?

One story that matters, taken past the headline. Each short episode picks a single current news story and goes deep — the background, the stakes, and why it matters — in a clear, calm brief. AI-produced by Elite Personas LLC.